Coastal Bridge Advisors’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Coastal Bridge Advisors’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,800	Closed	-$305	–	182
2024 Q2	$305	Hold	10,800	–	–	﹤0.01%	169
2024 Q1	$972	Hold	10,800	–	–	﹤0.01%	177
2023 Q4	$1.14K	Hold	10,800	–	–	﹤0.01%	175
2023 Q3	$2.43K	Hold	10,800	–	–	﹤0.01%	174
2023 Q2	$2.83K	Hold	10,800	–	–	﹤0.01%	167
2023 Q1	$1.94K	Hold	10,800	–	–	﹤0.01%	174
2022 Q4	$2.16K	Hold	10,800	–	–	﹤0.01%	174
2022 Q3	$8K	Hold	10,800	–	–	﹤0.01%	175
2022 Q2	$6K	Buy	+10,800	New	+$6.85K	﹤0.01%	161

Other funds holding DNA.WS

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Coastal Bridge Advisors's DNA.WS Position: Q3 2024 in Review

Coastal Bridge Advisors sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 10,800 shares — an estimated $305 sold.

Coastal Bridge Advisors first reported a position in DNA.WS in Q2 2022 and held it in 9 quarters. The position peaked at $8K in Q3 2022. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

Coastal Bridge Advisors reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
Coastal Bridge Advisors sold 10,800 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $305.
Coastal Bridge Advisors first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022 and held it in 9 quarters.
Coastal Bridge Advisors's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $8K in Q3 2022.
5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on Coastal Bridge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.